Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | %Female (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
171 | BMC Chemical Biology | journal | 1.418 Q1 | 21 | 0 | 14 | 0 | 45 | 14 | 1.14 | 0.00 | 0.00 | |
170 | BMC Clinical Pharmacology | journal | 0.644 Q2 | 43 | 0 | 53 | 0 | 146 | 53 | 2.59 | 0.00 | 0.00 | |
169 | BMC Pharmacology | journal | 1.120 Q1 | 48 | 0 | 38 | 0 | 140 | 38 | 2.82 | 0.00 | 0.00 | |
168 | Chemical Speciation and Bioavailability | journal | 0.218 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
167 | Current Opinion in Drug Discovery and Development | journal | 1.199 Q1 | 85 | 0 | 68 | 0 | 277 | 67 | 0.00 | 0.00 | 0.00 | |
166 | Current Opinion in Investigational Drugs | journal | 1.265 Q1 | 83 | 0 | 144 | 0 | 544 | 143 | 0.00 | 0.00 | 0.00 | |
165 | Current Opinion in Molecular Therapeutics | journal | 1.212 Q1 | 67 | 0 | 88 | 0 | 342 | 87 | 0.00 | 0.00 | 0.00 | |
164 | Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment | journal | 1.041 Q2 | 65 | 0 | 34 | 0 | 77 | 32 | 2.41 | 0.00 | 0.00 | |
163 | HIV Therapy | journal | 0.359 Q3 | 14 | 0 | 48 | 0 | 32 | 37 | 0.00 | 0.00 | 0.00 | |
162 | IDrugs : the investigational drugs journal | journal | 0.322 Q3 | 39 | 0 | 176 | 0 | 180 | 176 | 0.00 | 0.00 | 0.00 | |
161 | Journal of Applied Therapeutic Research | journal | 0.128 Q4 | 8 | 0 | 25 | 0 | 5 | 25 | 0.06 | 0.00 | 0.00 | |
160 | Journal of Immune Based Therapies and Vaccines | journal | 0.793 Q2 | 21 | 0 | 16 | 0 | 36 | 16 | 3.14 | 0.00 | 0.00 | |
159 | Life Science Clusters | trade journal | 0.102 Q4 | 0 | 0 | 11 | 0 | 0 | 10 | 0.00 | 0.00 | 0.00 | |
158 | MedChemComm | journal | 0.987 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
157 | Next Generation Pharmaceutical | trade journal | 0.100 Q4 | 1 | 0 | 112 | 0 | 0 | 57 | 0.00 | 0.00 | 0.00 | |
156 | Pharmaceutical Journal | journal | 0.105 Q4 | 28 | 0 | 2299 | 0 | 39 | 877 | 0.02 | 0.00 | 0.00 | |
155 | Pharmacy News | journal | 0.100 Q4 | 1 | 0 | 244 | 0 | 0 | 93 | 0.00 | 0.00 | 0.00 | |
154 | Quality Assurance Journal | journal | 0.107 Q4 | 11 | 0 | 24 | 0 | 3 | 22 | 0.15 | 0.00 | 0.00 | |
153 | RSC Drug Discovery Series | book series | 0.102 Q4 | 13 | 0 | 28 | 0 | 0 | 11 | 0.00 | 0.00 | 0.00 | |
152 | F1000 Biology Reports | journal | 1.635 Q1 | 32 | 2 | 138 | 163 | 391 | 137 | 4.68 | 81.50 | 0.00 | |
151 | Antiviral Chemistry and Chemotherapy | journal | 0.801 Q2 | 59 | 7 | 63 | 451 | 175 | 61 | 2.40 | 64.43 | 20.00 | |
150 | Autonomic and Autacoid Pharmacology | journal | 0.282 Q3 | 24 | 7 | 39 | 217 | 21 | 39 | 0.67 | 31.00 | 52.94 | |
149 | EPMA Journal | journal | 0.341 Q3 | 52 | 8 | 120 | 745 | 172 | 108 | 1.40 | 93.13 | 25.00 | |
148 | PharmacoVigilance Review | journal | 0.100 Q4 | 2 | 9 | 66 | 32 | 1 | 44 | 0.00 | 3.56 | 66.67 | |
147 | International Journal of Green Nanotechnology | journal | 0.122 Q4 | 5 | 10 | 0 | 308 | 0 | 0 | 0.00 | 30.80 | 32.00 | |
146 | Toxin Reviews | journal | 0.353 Q3 | 54 | 10 | 31 | 647 | 45 | 30 | 0.85 | 64.70 | 50.00 | |
145 | Journal of Pharmaceutical Policy and Practice | journal | 0.359 Q1 | 32 | 11 | 48 | 287 | 36 | 34 | 0.91 | 26.09 | 45.45 | |
144 | Journal of Venomous Animals and Toxins Including Tropical Diseases | journal | 0.180 Q4 | 41 | 12 | 210 | 500 | 114 | 188 | 0.45 | 41.67 | 23.33 | |
143 | Drugs in Context | journal | 0.107 Q4 | 36 | 13 | 3 | 461 | 0 | 3 | 0.00 | 35.46 | 30.77 | |
142 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.615 Q1 | 99 | 14 | 74 | 2197 | 389 | 68 | 5.04 | 156.93 | 37.29 | |
141 | GMP Review | trade journal | 0.103 Q4 | 2 | 16 | 40 | 31 | 2 | 39 | 0.05 | 1.94 | 23.08 | |
140 | Pharmaceutical Medicine | journal | 0.263 Q3 | 25 | 16 | 82 | 651 | 70 | 64 | 0.93 | 40.69 | 35.00 | |
139 | Pharmacology Research and Perspectives | journal | 43 | 16 | 0 | 635 | 0 | 0 | 0.00 | 39.69 | 37.38 | ||
138 | Drug Discovery Today: Disease Mechanisms | journal | 0.922 Q2 | 28 | 18 | 55 | 827 | 96 | 49 | 0.54 | 45.94 | 39.39 | |
137 | Journal of Negative Results in BioMedicine | journal | 0.536 Q1 | 25 | 18 | 42 | 562 | 60 | 42 | 1.41 | 31.22 | 27.38 | |
136 | Mathematical Medicine and Biology | journal | 0.640 Q2 | 49 | 18 | 45 | 597 | 88 | 43 | 1.84 | 33.17 | 25.00 | |
135 | Industrial Pharmacy | trade journal | 0.117 Q4 | 5 | 19 | 40 | 102 | 8 | 40 | 0.20 | 5.37 | 10.71 | |
134 | Journal for ImmunoTherapy of Cancer | journal | 117 | 21 | 0 | 1042 | 0 | 0 | 0.00 | 49.62 | 30.40 | ||
133 | Drug Discovery Today: Therapeutic Strategies | journal | 0.453 Q3 | 31 | 22 | 62 | 1225 | 87 | 55 | 1.58 | 55.68 | 29.41 | |
132 | Chinese Medicine | journal | 0.885 Q2 | 56 | 23 | 112 | 955 | 390 | 105 | 3.11 | 41.52 | 35.05 | |
131 | Human Genomics | journal | 1.266 Q1 | 68 | 24 | 98 | 1098 | 310 | 88 | 3.05 | 45.75 | 39.53 | |
130 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 25 | 55 | 1114 | 146 | 53 | 2.35 | 44.56 | 42.11 | ||
129 | International Journal of Computational Biology and Drug Design | journal | 0.200 Q4 | 16 | 27 | 75 | 720 | 34 | 68 | 0.46 | 26.67 | 26.03 | |
128 | European Journal of Parenteral and Pharmaceutical Sciences | journal | 0.270 Q2 | 7 | 30 | 59 | 159 | 15 | 47 | 0.28 | 5.30 | 30.77 | |
127 | Therapeutic Advances in Neurological Disorders | journal | 1.144 Q1 | 68 | 31 | 88 | 2319 | 397 | 86 | 4.82 | 74.81 | 48.65 | |
126 | Journal of Generic Medicines (discontinued) | journal | 0.160 Q3 | 16 | 32 | 105 | 481 | 32 | 91 | 0.27 | 15.03 | 26.79 | |
125 | Drugs in R and D | journal | 0.557 Q3 | 54 | 33 | 83 | 952 | 169 | 79 | 2.09 | 28.85 | 40.00 | |
124 | Journal of Occupational Medicine and Toxicology | journal | 0.448 Q3 | 47 | 33 | 87 | 1347 | 163 | 87 | 1.75 | 40.82 | 36.96 | |
123 | Pharmaceutical patent analyst | journal | 0.403 Q2 | 20 | 33 | 42 | 441 | 28 | 29 | 0.67 | 13.36 | 36.67 | |
122 | Drug Discovery Today: Disease Models | journal | 0.288 Q3 | 33 | 34 | 76 | 1646 | 53 | 67 | 0.70 | 48.41 | 36.62 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®